secwatch.observer — SEC 8-K summary
======================================

Issuer:     RenovoRx, Inc. (RNXT)
CIK:        0001574094
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0001493152-24-023128
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RenovoRx enters severance deal with VP/Controller Kocak; annual meeting re-elects six directors
--------------------------------------------------------------------------------

- Severance provides 50% of base salary on qualifying termination; 100% plus full equity vesting if within 12 months of a change in control.
- Kocak also receives 6 months COBRA (12 months in change in control) and pro-rata bonus.
- At June 6 annual meeting, all six nominees re-elected: Bagai, Agah, Macfarlane, Marton, Ryan, Spiegel.
- Agreement mirrors terms for other RenovoRx executive officers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1574094/000149315224023128/0001493152-24-023128-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1574094/000149315224023128/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-023128

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer